WallStreetZenWallStreetZen

NASDAQ: PXMD
Paxmedica Inc Earnings & Revenue

PXMD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$18.3M
Current Profit Margin
0%

PXMD Return on Equity

Current Company
-956.8%
Current Industry
-63.4%
Current Market
188%
PXMD's Return on Equity (-956.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PXMD announces earnings.

PXMD Return on Assets

Current Company
-388.9%
Current Industry
3.2%
PXMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PXMD Return on Capital Employed

Current Company
-470.53%
Current Industry
19.9%
PXMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PXMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PXMD$0.00-$18.28M-$18.29MN/AN/A
REVB$0.00-$95.21k-$120.25kN/AN/A
MYMD$0.00-$5.38M-$7.07M-100.00%N/A
GOVX$0.00-$25.89M-$25.97M-100.00%N/A
GNPX$0.00-$31.68M-$31.70MN/AN/A

Paxmedica Earnings & Revenue FAQ

What were PXMD's earnings last quarter?

Paxmedica (NASDAQ: PXMD) reported Q4 2023 earnings per share (EPS) of $3.39, up 144.78% year over year. Total Paxmedica earnings for the quarter were -$5.92 million. In the same quarter last year, Paxmedica's earnings per share (EPS) was -$7.57.

If you're new to stock investing, here's how to buy Paxmedica stock.

What was PXMD's earnings growth in the past year?

As of Q1 2024, Paxmedica's earnings has grown year over year. Paxmedica's earnings in the past year totalled -$18.29 million.

What was PXMD's revenue last quarter?

Paxmedica (NASDAQ: PXMD) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Paxmedica's revenue was $0.00.

What was PXMD's revenue growth in the past year?

As of Q1 2024, Paxmedica's revenue has grown null year over year. Paxmedica's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.